Literature DB >> 7092533

Rehabilitation management of muscular dystrophy and related disorders: I. The role of exercise.

W M Fowler, M Taylor.   

Abstract

When evaluating the effect of a modality such as exercise, maturation in children, the rate of progression of the disease, and the degree of weakness should be considered. The two major factors critical in producing overwork weakness are the degree of weakness at the time the exercise program is started and the intensity of the exercise training program. Exercise therapy is apparently not harmful and may be beneficial in patients with motor unit diseases if it is started early in the course of the diseases when muscle fiber degeneration is minimal, and is carried out at submaximal levels.

Entities:  

Mesh:

Year:  1982        PMID: 7092533

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

1.  Respiratory failure and mechanical ventilation: pathophysiology and methods of promoting weaning.

Authors:  J P Karpel; T K Aldrich
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline Bm Voet; Elly L van der Kooi; Baziel Gm van Engelen; Alexander Ch Geurts
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

3.  Changes in motor function in Duchenne muscular dystrophy patients after travel restrictions due to COVID-19.

Authors:  Hitomi Nishizawa; Akinori Nakamura
Journal:  Muscle Nerve       Date:  2021-06-22       Impact factor: 3.852

Review 4.  What are the effects of strength training and aerobic exercise training for muscle disease? - A Cochrane Review summary with commentary.

Authors:  Ayesha Afridi; Farooq Azam Rathore
Journal:  J Rehabil Med       Date:  2021-09-24       Impact factor: 2.912

5.  Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).

Authors:  Maria Elena Lombardo; Elena Carraro; Cristina Sancricca; Michela Armando; Michela Catteruccia; Elena Mazzone; Giulia Ricci; Ferdinando Salamino; Filippo Maria Santorelli; Massimiliano Filosto
Journal:  Acta Myol       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.